Form 4: Quest Diagnostics Director Acquires Shares Through Restricted Stock Unit Award

Robert B. Carter, a director at Quest Diagnostics, acquired 1,482 shares of common stock through a restricted stock unit award on May 16, 2024.

Summary

• Robert B. Carter, a director of Quest Diagnostics, acquired 1,482 shares of common stock on May 16, 2024.
• The acquisition was through a restricted share unit award.
• Following the transaction, Carter directly owns 1,482 shares of Quest Diagnostics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a stock acquisition by a director through a restricted stock unit award. While insider buying can be seen as positive, it's not necessarily a strong indicator of future performance.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be informative for investors.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates